2005
DOI: 10.1016/j.jhin.2004.09.021
|View full text |Cite
|
Sign up to set email alerts
|

Control of an outbreak of multi-drug-resistant Acinetobacter baumannii in an intensive care unit and a surgical ward

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0
2

Year Published

2007
2007
2019
2019

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(25 citation statements)
references
References 10 publications
0
23
0
2
Order By: Relevance
“…With the wide application of antibacterial drugs, bacterial drug resistance is sharply increasing and multi-drug resistant bacterial strains are evolving, causing great difficulties in clinical treatment. Hospital infections caused by A. baumannii are generally on the rise, and this is the main pathogen reported in some intensive care units (Pimentel et al, 2005). The infection rate of multi-drug resistant A. baumannii has drawn clinical attention (Oliveira and de Lencastre, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…With the wide application of antibacterial drugs, bacterial drug resistance is sharply increasing and multi-drug resistant bacterial strains are evolving, causing great difficulties in clinical treatment. Hospital infections caused by A. baumannii are generally on the rise, and this is the main pathogen reported in some intensive care units (Pimentel et al, 2005). The infection rate of multi-drug resistant A. baumannii has drawn clinical attention (Oliveira and de Lencastre, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…This risk of nosocomial infection is further escalated by the increasing prevalence of antibiotic-resistant pathogens such as methicillin (oxacillin)-resistant S. aureus (MRSA) and vancomycin-resistant Enterococci (VRE) among Gram-positive organisms, and multi-drug resistant (MDR) Pseudomonas aeruginosa and Acinetobacter among Gramnegative organisms. Especially, Acinetobacter baumannii is becoming a major hospital-acquired infection issue because it is often multi-drug resistant (Wang et al, 2003;Marais et al, 2004;Pimentel et al, 2005;Wilks et al, 2006;Apisarnthanarak et al, 2008). This contributes to the increase of morbidity and mortality.…”
Section: Introductionmentioning
confidence: 99%
“…The analysis of the molecular epidemiology and multidrug resistance of A. baumanni strains in the various parts of the world indicates a considerable degree of geographic diversity in the spread of various strains [23,24,25,26]. It's also demonstrated by multiple studies in Tunisia [20,21,27] and in France [28,29,30] that the multiresistance is common among A.baumannii giving nosocomial epidemics which were difficult to treat.…”
Section: Discussionmentioning
confidence: 99%